EP 4146189 A1 20230315 - GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING
Title (en)
GLYCERYLTRIACETATE (GTA) FOR USE IN IMPROVING BREATHING
Title (de)
GLYCERYLTRIACETAT (GTA) ZUR VERWENDUNG BEI DER VERBESSERUNG DER ATMUNG
Title (fr)
GLYCÉRYLTRIACÉTATE (GTA) À UTILISER POUR AMÉLIORER LA RESPIRATION
Publication
Application
Priority
- US 202063019538 P 20200504
- IL 2021050505 W 20210503
Abstract (en)
[origin: WO2021224912A1] The present disclosure relates to glyceryltriacetate (GTA) compound for use in improving breathing in a subject experiencing a breathing difficulty. Of particular interest is the use of GTA for treating reduced lung function, such as that caused by lung infection and/or lung inflammation. Also disclosed is thus a composition and method for improving breathing of a subject experiencing a breathing difficulty.
IPC 8 full level
A61K 31/216 (2006.01); A61K 31/225 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 11/08 (2006.01); A61P 11/14 (2006.01)
CPC (source: EP IL US)
A61K 9/4825 (2013.01 - US); A61K 31/216 (2013.01 - EP IL US); A61K 31/225 (2013.01 - EP IL US); A61P 11/00 (2017.12 - EP IL US); A61P 11/06 (2017.12 - EP IL); A61P 11/08 (2017.12 - EP IL); A61P 11/14 (2017.12 - EP IL); A61K 2300/00 (2013.01 - IL)
Citation (search report)
See references of WO 2021224912A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021224912 A1 20211111; EP 4146189 A1 20230315; IL 297826 A 20230101; US 2023338322 A1 20231026
DOCDB simple family (application)
IL 2021050505 W 20210503; EP 21726210 A 20210503; IL 29782622 A 20221031; US 202117997840 A 20210304